New skin cancer treatment added to the Pharmaceutical Benefits Scheme

The federal government has announced the listing of a new treatment in the Pharmaceutical Benefits Scheme [[P-B-S]] for patients suffering from advanced melanoma. The drug called Opdualag is set to be listed under the PBS from February 1 as part of the government's expansion of the national scheme.